• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ALINITY I TOTAL B-HCG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ALINITY I TOTAL B-HCG Back to Search Results
Catalog Number 07P51-20
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/06/2020
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product list 7p51-20, that has a similar us product distributed in the us, list 7p51-21 and 7p51-31.Patient identifier does not contain enough spaces, the entire id (b)(6).An evaluation is in process.A follow up report will be submitted when the evaluation is completed.
 
Event Description
The account generated false positive alinity i total b-hcg of 218 miu/ml on (b)(6) 2020 with id (b)(6) ((b)(6)) which did not match the expected result.New samples from (b)(6) 2020 tested negative.The original sample was repeated with a positive result of 80 miu/ml.No impact to patient management was reported.No gender, ethnicity and race was not provided.
 
Manufacturer Narrative
The ticket search determined normal complaint activity for the lot.Complaint trending report review determined that there is no adverse trend for the product for the current complaint issue.Labelling was reviewed and concluded that the issue is sufficiently addressed.A review of the product quality history for the lot number using search of the corrective and preventative actions system did not identify issues associated with the customers observation.A testing protocol was executed using in house retained samples of reagent lot 06112ui00.All validity and acceptance criteria were met during the completion of this protocol, demonstrating that this lot is performing acceptably.No customer returns were available for evaluation.No product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I TOTAL B-HCG
Type of Device
B-HCG
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD
lisnamuck
co. longford
longford NA
EI  NA
MDR Report Key9691281
MDR Text Key220800766
Report Number3005094123-2020-00037
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 04/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/24/2020
Device Catalogue Number07P51-20
Device Lot Number06112UI00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/16/2020
Initial Date FDA Received02/11/2020
Supplement Dates Manufacturer Received03/31/2020
Supplement Dates FDA Received04/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALINITY I PROCESSING MODULE LIST 03R65-01; ALINITY I PROCESSING MODULE LIST 03R65-01; SERIAL (B)(6) ; SERIAL (B)(6)
Patient Age42 YR
-
-